-+ 0.00%
-+ 0.00%
-+ 0.00%

Immutep's Abstract On IMP761 Accepted For Poster Presentation At ACR Convergence 2026

Benzinga·10/19/2026 12:05:22
语音播报

• Late-breaking poster will present data from the first-in-human Phase I study of IMP761, a first-in-class LAG-3 agonist antibody, in healthy volunteers